Overview
A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules
Status:
Completed
Completed
Trial end date:
2006-07-01
2006-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
SandozTreatments:
Indomethacin
Criteria
Inclusion Criteria:- No clinically significant abnormal findings on physical exam, medical history or
clinical laboratory results on screening
Exclusion Criteria:
- Positive test results for HIV or hepatitis B or C
- No allergies to indomethacin or related drugs